- Aug 2022
-
www.nature.com www.nature.com
-
Kozlov, M. (2022). Why scientists are racing to develop more COVID antivirals. Nature, 601(7894), 496–496. https://doi.org/10.1038/d41586-022-00112-8
-
- Mar 2022
-
www.cnn.com www.cnn.com
-
CNN, A. S. (n.d.). Pfizer begins Phase 2 and 3 trial of Covid-19 antiviral Paxlovid in children ages 6 to 17. CNN. Retrieved 22 March 2022, from https://www.cnn.com/2022/03/09/health/pfizer-paxlovid-pediatric-trial/index.html
-
- Feb 2022
-
-
Mancini, D. P., & Smyth, J. (2022, February 16). Merck struggles to win European approval for Covid-19 antiviral pill. Financial Times. https://www.ft.com/content/2cf0b6cc-b07b-4ff9-a833-42eb1798a576
-
- Jan 2022
-
medicalxpress.com medicalxpress.com
-
Tong-Hyung, K. (n.d.). South Korea gets first supply of Pfizer’s COVID-19 pills. Retrieved January 20, 2022, from https://medicalxpress.com/news/2022-01-south-korea-pfizer-covid-pills.html
-
- Dec 2021
-
-
Mahase, E. (2021). Covid-19: Do vaccines work against omicron—and other questions answered. BMJ, 375, n3062. https://doi.org/10.1136/bmj.n3062
Tags
- PCR
- EU
- treatment
- research
- Omicron
- antiviral
- work from home
- restrictions
- severity
- infection rate
- Africa
- variant
- booster
- delta
- South Africa
- hospitalization
- travel ban
- mask wearing
- modeling
- domestic measures
- testing
- response
- antibody
- vaccine
- Europe
- is:article
- reinfection
- detection
- COVID-19
- risk
- epidemiology
- UK
- transmissibility
- lang:en
- mutation
- data
Annotators
URL
-
- Nov 2021
-
www.theguardian.com www.theguardian.com
-
France-Presse, A. (2021, November 17). Pfizer strikes deal to allow generic versions of its Covid pill for world’s poor. The Guardian. https://www.theguardian.com/business/2021/nov/17/pfizer-strikes-deal-to-allow-generic-versions-of-its-covid-pill-for-worlds-poor
Tags
- antiviral pill
- royalty
- cost
- treatment
- funding
- vaccine
- COVID-19
- income
- lang:en
- manufacturer
- public health emergency
- is:news
- Paxlovid
- approval
- Pfizer
Annotators
URL
-
-
www.science.org www.science.org
-
Couzin-Frankel, J. (2021). Antiviral pills could change pandemic’s course. Science, 374(6569), 799–800. https://doi.org/10.1126/science.acx9605
-
- Sep 2020
-
pittsburgh.cbslocal.com pittsburgh.cbslocal.com
-
University Of Pittsburgh Scientists Discover Biomolecule That May Neutralize Coronavirus. (2020, September 15). https://pittsburgh.cbslocal.com/2020/09/15/coronavirus-university-pittsburgh-biomolecule-neutralize/
-
- Jul 2020
-
www.sciencedirect.com www.sciencedirect.com
-
Sun, J., Zhuang, Z., Zheng, J., Li, K., Wong, R. L.-Y., Liu, D., Huang, J., He, J., Zhu, A., Zhao, J., Li, X., Xi, Y., Chen, R., Alshukairi, A. N., Chen, Z., Zhang, Z., Chen, C., Huang, X., Li, F., … Zhao, J. (2020). Generation of a Broadly Useful Model for COVID-19 Pathogenesis, Vaccination, and Treatment. Cell. https://doi.org/10.1016/j.cell.2020.06.010
-
-
www.frontiersin.org www.frontiersin.org
-
Zhou, Q., Chen, V., Shannon, C. P., Wei, X.-S., Xiang, X., Wang, X., Wang, Z.-H., Tebbutt, S. J., Kollmann, T. R., & Fish, E. N. (2020). Interferon-α2b Treatment for COVID-19. Frontiers in Immunology, 11. https://doi.org/10.3389/fimmu.2020.01061
-
- May 2020
-
www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
-
Wang, C., Li, W., Drabek, D. et al. A human monoclonal antibody blocking SARS-CoV-2 infection. Nat Commun 11, 2251 (2020). https://doi.org/10.1038/s41467-020-16256-y
-
-
www.thelancet.com www.thelancet.com
-
Lipsitch, M., Perlman, S., & Waldor, M. K. (2020). Testing COVID-19 therapies to prevent progression of mild disease. The Lancet Infectious Diseases, 0(0). https://doi.org/10.1016/S1473-3099(20)30372-8
-
- Apr 2020
-
www.thelancet.com www.thelancet.com
-
Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245–1246. https://doi.org/10.1016/S0140-6736(20)30894-1
-